, Tracking Stock Market Picks
Enter Symbol:
Rating: HOLX
Buy $40
up 14.00 %

Hologic, Inc. (NASDAQ: HOLX) reiterated to Buy with price target $40 by Canaccord Genuity

Monday,  Jun 1, 2015  9:25 AM ET by Lynn Gilbert

Canaccord Genuity reiterated Hologic, Inc. (NASDAQ: HOLX) to Buy with price target $40. Previously, Canaccord Genuity rated Hologic, Inc. (NASDAQ: HOLX) to Buy with price
target $37 on 02/19/2015, when the stock price was valued at $31.55. Since then, Hologic, Inc.'s stock price has gained 14% as of 06/01/2015's recent price of $35.82.
If you had followed Canaccord Genuity's previous recommendation on HOLX, you would have gained 14% of your investment in 102 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy